Figure2 Comparison of lipid profiles of the patients with RA
between treated and baseline in the two groups of 99Tc
and 99Tc & GC Lipid profiles were measured after
treatment of 99Tc-MDP and or glucocorticoids (as
Treated) and before (as baseline) including CHO, TG, and HDL-C, LDL-C,
and ApoA1, ApoB from Figure 2 A-F. non fasting lipids including the
ratio of ApoB/ApoA1 and atherogenic index presented in figure of G and
H. The levels of TG and ApoA1 were significantly increased in the group
of 99Tc, the P values were separately 0.0441 and
0.0179 (B, E). The ratio of ApoB/ApoA1 was decreased in Figure 2G. In
the group of 99Tc & GC, the levels of CHO, TG and
HDL-C, ApoA1 were elevated after treatment (All P values <
0.05) (A, B, C, E). In Figure 2G and 2H, the ratio of ApoB/Apo A1 and
atherogenic index were decreased with P <0.05.